Case Study: a global pharmaceutical company achieves real-time clinical trial enrollment forecasting with Axtria

Global Pharmaceutical Company improves enrollment forecasting with Axtria’s real-time AI

A global pharmaceutical company faced significant challenges managing a multi-country Phase 3 clinical trial. Their static enrollment forecasts were fragmented and required manual interpretation, preventing leadership from consistently comparing performance and identifying delays early enough to intervene. To address this, they partnered with Axtria for a solution.

Axtria deployed a three-phase Bayesian enrollment modeling solution that replaced the client's static forecasts with real-time, predictive intelligence. This AI-powered engine continuously updated its predictions as new data emerged, generating probability distributions for site-level recruitment. The outcome was the early identification of underperforming sites, enabling targeted interventions and data-driven deactivation decisions that protected timelines and reduced costs. Axtria's solution also standardized reporting, giving leadership a single source of truth for performance comparisons.

Global Pharmaceutical Company